Laura Richman

Laura has authored or co-authored over 50 INDs and three BLAs. She was most recently the Senior Vice President of R&D at Arcellx. Prior to that, she was the Executive Director of the University of Pennsylvania’s Gene Therapy Program, where she led the preclinical development of more than 20 gene therapy programs across CNS, liver metabolic, ocular, and respiratory diseases. Before this, she was Vice President, of Translational Sciences at MedImmune. Laura is an author of more than 60 publications. She is a veterinary pathologist and molecular virologist by training, with a D.V.M. from the University of Wisconsin, Madison, and a Ph.D. from Johns Hopkins School of Medicine.